Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
CNSY

Cerenome, Inc. (CNSY)

NASDAQ
$0.69
+$0.05
(+7.52%)
Previous Close: ⁦$0.63⁩
Market Closed

Last updated: ⁦2026-11-19 02:54:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Cerenome, Inc. (CNSY) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.69, with a market capitalization of $6.99M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.43 to $4.25. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$6.99M

$0.64

$0.78

$0.63

$0.63

512.33K

803.31K

--

$4.25

$0.43

--

2026-09-30

Cerenome, Inc. (CNSY) Latest Closing Stock Price

Cerenome, Inc. (CNSY) last closed at $0.69 as of 2026-11-19 01:00:00, up 7.52% ($0.05) from the previous close of $0.63.

During the latest regular trading session, CNSY traded between $0.63 and $0.78, with a volume of 512.33K shares. The closing price was near the middle and near the lower end of its 52-week range.

Why Is CNSY Stock Down Today?

CNSY is down 12.06% as of the last close.

Cerenome shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $1 to $7.

Source: Benzinga · Updated

Cerenome, Inc. (CNSY) 7-Day Stock Price Change

Over the past seven days, Cerenome, Inc. (CNSY) moved from $0.57 to $0.69, representing a gain of 21.10% ($0.12).

The stock traded between $0.43 and $1.18 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 1.67 million shares, down versus the previous seven-day period, indicating lower trading activity.

CNSY 52-Week Price Position

Position in Range: 6.8%

52W Low$0.43
52W High$4.25

CNSY is currently trading at $0.69, placing it 6.8% of the way from its 52-week low of $0.43 to its 52-week high of $4.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cerenome, Inc. (CNSY)?

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Cerenome, Inc. Information

Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
28
Exchange
NASDAQ
Company Website

CNSY News

Latest news related to Cerenome, Inc. and CNSY stock.

  • Benzinga

    NVIDIA To $230? Here Are 10 Top Analyst Forecasts For Wednesday

    Wall Street analysts adjusted targets for HD, DUOT, CNSY, ECL, DLB, NVDA and KLAR, while maintaining their existing ratings.

    Read Full Article
  • Benzinga

    HC Wainwright & Co. Maintains Buy on Cerenome, Raises Price Target to $7

    HC Wainwright & Co. analyst Sean Lee maintains Cerenome (NASDAQ:CNSY) with a Buy and raises the price target from $1 to $7.

    Read Full Article
  • Benzinga

    Cerenome Says No LM Progression At 3, 6 Months In 5 Evaluable Patients; 1 Of 4 Progressed By 9 Months

    Read Full Article
  • Benzinga

    Cerenome Reports Interim Phase 1 ReSPECT-LM Data For Reyobiq In Leptomeningeal Metastases; No Dose-Limiting Toxicities In First 10 Patients

    Read Full Article
  • Benzinga

    Cerenome Announced Interim Data From Its Ongoing ReSPECT-LM Study Of Repeated Intraventricular Dosing Of REYOBIQ; No Dose-Limiting Toxicities Or Adverse Events Leading To Treatment Discontinuation Have Been Reported

    Cerenome, Inc. (NASDAQ:CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted radiopharmaceuticals, and artificial

    Read Full Article

Ways to Trade CNSY at MEXC

CNSY MEXC RealStocks

Own real CNSY shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Cerenome, Inc. (CNSY) Stock on MEXC

Eligible investors can buy real shares of Cerenome, Inc. (CNSY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for CNSY and Place Your Order
Step 3: Search for CNSY and Place Your Order
Open the RealStocks trading page and search for CNSY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cerenome, Inc. (CNSY) stock price today?
Cerenome, Inc. (CNSY) is currently trading at $0.69, up 7.52% ($0.05) from the previous close of $0.63. Intraday prices update in real time during regular trading hours.
2.Is CNSY stock going up or down today?
As of 2026-11-19 01:00:00, CNSY is trading at $0.69, up 7.52% ($0.05) from its previous close of $0.63. The stock has traded between $0.63 and $0.78 during today’s regular session. Past price movements do not guarantee future results.
3.What is CNSY pre-market price?
As of 2026-11-19 01:00:00, CNSY is trading at $0.67 in pre-market trading, up 6.46% ($0.04) from the previous close of $0.63. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is CNSY after-hours price?
As of 2026-11-19 01:00:00, CNSY is trading at $0.76 in after-hours trading, up 9.57% ($0.07) from the regular-session close of $0.69. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is CNSY stock trading now?
CNSY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does CNSY sit relative to its 52-week high and low?
Over the past 52 weeks, CNSY has traded between a low of $0.43 and a high of $4.25. At $0.69, the stock is positioned 6.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Cerenome, Inc. in?
Cerenome, Inc. (CNSY) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Cerenome, Inc.'s market capitalization and where is it listed?
Cerenome, Inc. is listed on the NASDAQ exchange with a market capitalization of $6.99M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is CNSY valued in terms of P/E ratio and EPS?
CNSY trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-3.10. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Cerenome, Inc. pay a dividend?
Cerenome, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CNSY, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

CNSY Stock Calculator

Estimate the value between CNSY shares and USD.

CNSY Shares to USD

CNSY Shares
CNSY
CNSY
USD
USD
USD

1.00 CNSY shares = 0.69 USD

Calculations are estimates based on the latest available price and are for reference only.